ELI LILLY & Co
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3024% above fair value
$1409.38−1.61 (-0.11%)
Close on Nov 3, 2026Market cap $1.33TP/E 45.7Yield 0.44%
Eli Lilly Outside U.S. foreign exchange impact YoY by Year
Outside U.S. foreign exchange impact YoY (%) (%)
Eli Lilly Outside U.S. foreign exchange impact YoY: 2.0% in FY2025, up 3.0 pts from a year earlier.
Latest, FY2025
2.0%
Period ended Dec 31, 2025
Change on a year earlier
+3.0 pts
-1.0% in FY2024
History
7 years
Since FY2018
Sources
7
Documents cited below
Where the FY2025 figure comes from
“|| Foreign exchange rates | — | % | 2 | % | 1 | %”
Source: Form 10-K FY2025 (filed 2026-02-12) ↗
Reported in Form 10-Q / 10-K MD&A & Form 8-K Q4 Releases.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Outside U.S. foreign exchange impact YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.0% | +3.0 pts | Form 10-K FY2025 (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | -1.0% | 0.0 pts | Form 10-K FY2024 (filed 2025-02-19) ↗ |
| FY2023 | Dec 31, 2023 | -1.0% | +7.0 pts | Form 10-K FY2023 (filed 2024-02-21) ↗ |
| FY2022 | Dec 31, 2022 | -8.0% | -11.0 pts | Form 10-K FY2022 (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 3.0% | – | Form 10-K FY2021 (filed 2022-02-23) ↗ |
| FY2019 | Dec 31, 2019 | -3.0% | -5.0 pts | Form 10-K FY2019 (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 2.0% | – | Form 10-K FY2018 (filed 2019-02-19) ↗ |
Cite this data
StockData. (2026). Eli Lilly Outside U.S. foreign exchange impact YoY (%), annual FY2018–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/rev-growth-nonus-fx
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.
See a number that looks wrong?